Vermillion this week reported that fourth-quarter OVA1 sales increased 40 percent year over year in preliminary results.

During an earnings call following release of the results, however, CEO Gail Page said that the company has in recent quarters "observed a plateau in OVA1 growth" and suggested that reimbursement problems could be behind this slowdown.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.